[Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
D000230:Adenocarcinoma / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology*; D014594:Uterine Neoplasms / Q000276:immunology*
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D015295:Antigens, Tumor-Associated, Carbohydrate